Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabidiol cognitive outcomes in pediatric Lennox-Gastaut Syndrome
NCT04133480Phase 4Withdrawn
- Sponsor
- Jazz Pharmaceuticals plc
- Start
- Oct 2020
- Primary completion
- Dec 2021
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of cannabidiol in Lennox-Gastaut syndrome (LGS), sponsored by Jazz Pharmaceuticals plc. Planned start Oct 2020; status: withdrawn.
02
Drugs
cannabidiol
03
Conditions
Lennox-Gastaut syndrome (LGS)
Beyond the preview
Go deeper on NCT04133480.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04133480.